Insiders Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 11:35:00 2024-05-21 am EDT			5-day change	1st Jan Change
1.925 ^GBX	+10.00%		-3.75%	-71.27%

May. 10	Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	Apr. 30	AN
Shield Therapeutics hires former Akili leader as new CFO	Jan. 09	AN
Shield Therapeutics Names New CFO	Jan. 09	MT
Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024	Jan. 08	CI
Shield Therapeutics Chief Financial Officer Rudolf to leave	23-10-12	AN
Shield Therapeutics CFO to Step Down	23-10-12	MT
Aston Martin CEO ups stake; Alkemy's lithium deal	23-10-03	AN
UK's Shield Therapeutics Names Chief Commercial Officer	23-04-05	MT
Shield appoints Andy Hurley as chief commercial officer	23-04-05	AN
Shield Therapeutics plc Announces Appointment of Andy Hurley as Chief Commercial Officer, Effective 10 April 2023	23-04-05	CI
TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps	23-01-09	AN
Shield Therapeutics : Names New Chief Medical Officer	21-09-27	MT
Shield Therapeutics : Jose A. Menoyo MD Appointed as Chief Medical Officer	21-09-27	PU
Shield Therapeutics plc Announces Management Changes	21-09-27	CI
Shield Therapeutics plc Announces Executive Changes, Effective June 1, 2021	21-05-28	CI
Shield Therapeutics plc Announces Board Changes	21-05-28	CI
Shield Therapeutics plc Announces Board Changes	21-05-10	CI
Shield Therapeutics plc Appoints Hans-Peter Rudolf as Chief Financial Officer	21-03-22	CI
Shield Therapeutics plc Appoints Christian Schweiger as Non-Executive Director	20-06-26	CI
Shield Therapeutics plc Announces Management Changes	20-05-26	CI

No results for this search